Fresenius Medical Care Ag & Co. Kgaa
Volume 164 · 164 F.T.C. 1123
Cite this decision
Fresenius Medical Care Ag & Co. Kgaa, 164 F.T.C. 1123 (2017). Consumer Law Library, https://consumerlawlibrary.org/decisions/v164-0038
Report an error in this record (decision id v164-0038)
Cited by 0 later FTC decisions
Cites
Text (OCR of the scan at left; may contain errors)
IN THE MATTER OF FRESENIUS MEDICAL CARE AG & CO. KGAA Docket No. C-4348. Order, December 15, 2017 Letter Order approving respondent’s application to establish a dialysis clinic LETTER ORDER APPROVING APPLICATION Mr. Brian F. Burke, Esq.
Baker & McKenzie LLP Re: Fresenius Medical Care AG & CO. Kgaa, Docket No. C-4348 Dear Mr. Burke, Pursuant to Rule 2.41(f) of the Commission’s Rules of Practice, the Commission has determined to approve the Application of Fresenius Medical Care AG & CO. Kgaa (“Fresenius”) (October 4, 2017) to establish a dialysis clinic at 5311 Clyde Park Avenue, SW, Wyoming, Michigan, a location that was previously divested to DSI by Fresenius as a de novo dialysis clinic pursuant to the Commission Order in the above matter. The property was never developed into a dialysis clinic and has been vacant for over five years. In according its approval to Fresenius’s Application, the Commission has relied upon the information submitted by Fresenius, and the Commission has assumed that information to be accurate and complete. By direction of the Commission.
VOLUME 164 Interlocutory Orders, Etc.